Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? (Q39156308)
Jump to navigation
Jump to search
scientific article published on 10 April 2017
Language | Label | Description | Also known as |
---|---|---|---|
English | Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? |
scientific article published on 10 April 2017 |
Statements
1 reference
Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs? (English)
1 reference
Amira Mohamed
David Romano
Catherine Roche
Patricia Niccoli
Stephane Garcia
Vincent Moutardier
Anne Barlier
10 April 2017
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference